Combination vorinostat and lapatinib reverses epithelial-mesenchymal transition, inhibits the cancer stem cell population of HER2+ breast cancer cells and is effective in heavily pretreated advanced tumors Meeting Abstract


Authors: Schech, A. J.; Chumsri, S.; Shah, P.; Yu, S. L.; Tait, N. S.; Bauer, K. S.; Lewis, J. C.; Bao, T.; Edelman, M. J.; Tkaczuk, K. H.; Brodie, A. H.
Abstract Title: Combination vorinostat and lapatinib reverses epithelial-mesenchymal transition, inhibits the cancer stem cell population of HER2+ breast cancer cells and is effective in heavily pretreated advanced tumors
Meeting Title: 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 75
Issue: 9 Suppl.
Meeting Dates: 2014 Dec 9-13
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2015-05-01
Language: English
ACCESSION: WOS:000356730203157
DOI: 10.1158/1538-7445.sabcs14-p5-19-05
PROVIDER: wos
Notes: Meeting Abstract: P5-19-05 -- 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium -- DEC 09-13, 2014 -- San Antonio, TX -- S -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ting   Bao
    76 Bao
Related MSK Work